Blinded independent central review of progression in cancer clinical trials: results from a meta-analysis. [electronic resource]
Producer: 20111003Description: 1772-8 p. digitalISSN:- 1879-0852
- Antineoplastic Agents -- therapeutic use
- Bias
- Clinical Trials, Phase III as Topic -- methods
- Disease Progression
- Disease-Free Survival
- Humans
- Medical Audit
- Neoplasms -- drug therapy
- Odds Ratio
- Randomized Controlled Trials as Topic -- methods
- Sensitivity and Specificity
- Single-Blind Method
- United States
No physical items for this record
Publication Type: Journal Article; Meta-Analysis
There are no comments on this title.
Log in to your account to post a comment.